AR010369A1 - Antagonista de receptor vitronectina, su preparacion asi como su empleo. - Google Patents
Antagonista de receptor vitronectina, su preparacion asi como su empleo.Info
- Publication number
- AR010369A1 AR010369A1 ARP970105994A ARP970105994A AR010369A1 AR 010369 A1 AR010369 A1 AR 010369A1 AR P970105994 A ARP970105994 A AR P970105994A AR P970105994 A ARP970105994 A AR P970105994A AR 010369 A1 AR010369 A1 AR 010369A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- well
- job
- receptor antagonist
- vitronectin receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Abstract
Antagonistas de receptor vitronectina, su preparacion así como su empleo. Son compuestos de la formula I, en donde A, B, D, E, F y G tienen lossignificados dados en las reivindicaciones, su preparacion y su empleo como medicamento. Loscompues tos son empleados como antagonistas de recetores devitronectina y como inhibidores de la resorcion osea.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19653645A DE19653645A1 (de) | 1996-12-20 | 1996-12-20 | Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
AR010369A1 true AR010369A1 (es) | 2000-06-07 |
Family
ID=7815760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970105994A AR010369A1 (es) | 1996-12-20 | 1997-12-18 | Antagonista de receptor vitronectina, su preparacion asi como su empleo. |
Country Status (19)
Country | Link |
---|---|
US (1) | US5990145A (es) |
EP (1) | EP0854145A3 (es) |
JP (1) | JPH10182617A (es) |
KR (1) | KR19980064419A (es) |
CN (1) | CN1200373A (es) |
AR (1) | AR010369A1 (es) |
AU (1) | AU729760B2 (es) |
BR (1) | BR9706386A (es) |
CA (1) | CA2225267A1 (es) |
CZ (1) | CZ411297A3 (es) |
DE (1) | DE19653645A1 (es) |
HU (1) | HUP9702509A3 (es) |
ID (1) | ID19245A (es) |
IL (1) | IL122643A0 (es) |
NO (1) | NO975975L (es) |
NZ (1) | NZ329429A (es) |
PL (1) | PL323968A1 (es) |
TR (1) | TR199701645A2 (es) |
ZA (1) | ZA9711315B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19647380A1 (de) * | 1996-11-15 | 1998-05-20 | Hoechst Ag | 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
BR9916518A (pt) | 1998-12-23 | 2002-01-29 | Searle & Co | Método para tratar ou prevenir um distúrbio de neoplasia em um mamìfero em necessidade de tal tratamento ou prevenção, e, combinação compreendendo um inibidor de ciclooxigenase-2 e um ou mais agentes anti-neoplásticos |
US6545032B1 (en) * | 1999-09-17 | 2003-04-08 | Torrey Pines Institute For Molecular Studies | Synthesis of [3,5,7]-H-imidazo[1,5-a] imidazol-2(3H)-one compounds |
DE10028575A1 (de) | 2000-06-14 | 2002-03-14 | Basf Ag | Integrinliganden |
DK1371646T3 (da) * | 2001-03-19 | 2010-07-05 | Dainippon Sumitomo Pharma Co | Arylsubstitueret alicyklisk forbindelse og medicinsk præparat omfattende det samme |
KR100861466B1 (ko) | 2001-04-24 | 2008-10-02 | 메르크 파텐트 게엠베하 | 항혈관형성제 및 TNFα를 이용한 병용 요법 |
JP4750360B2 (ja) | 2001-10-22 | 2011-08-17 | ザ スクリプス リサーチ インスティチュート | 抗体ターゲッティング化合物 |
NZ532463A (en) | 2001-11-13 | 2007-02-23 | Dimensional Pharm Inc | Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
US7205315B2 (en) * | 2003-09-27 | 2007-04-17 | Sanofi-Aventis Deutschland Gmbh | Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases |
US20070122408A1 (en) * | 2005-10-20 | 2007-05-31 | The Scripps Research Institute | Fc Labeling for Immunostaining and Immunotargeting |
US8618115B2 (en) * | 2005-10-26 | 2013-12-31 | Bristol-Myers Squibb Company | Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them |
JP2009523813A (ja) | 2006-01-18 | 2009-06-25 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 癌を治療するためにインテグリンのリガンドを使用する特異的な治療法 |
US7553836B2 (en) * | 2006-02-06 | 2009-06-30 | Bristol-Myers Squibb Company | Melanin concentrating hormone receptor-1 antagonists |
KR20090108713A (ko) | 2007-01-18 | 2009-10-16 | 메르크 파텐트 게엠베하 | 인테그린 리간드를 사용하는 암치료용 특이적 요법 및 의약 |
CA2680275C (en) | 2007-03-09 | 2016-08-23 | Renovis, Inc. | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
PE20091928A1 (es) * | 2008-05-29 | 2009-12-31 | Bristol Myers Squibb Co | Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos |
JP2012517447A (ja) | 2009-02-10 | 2012-08-02 | ザ スクリプス リサーチ インスティチュート | 化学的にプログラムされたワクチン接種法 |
NZ597339A (en) | 2009-05-25 | 2013-10-25 | Merck Patent Gmbh | Continuous administration of cilengitide in cancer treatments |
CN106572997A (zh) | 2014-05-30 | 2017-04-19 | 辉瑞公司 | 作为选择性雄激素受体调节剂的腈衍生物 |
WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE228115T1 (de) * | 1991-06-28 | 2002-12-15 | Smithkline Beecham Corp | Bizyklische fibrinogenantagonisten |
US5204350A (en) * | 1991-08-09 | 1993-04-20 | Merck & Co., Inc. | Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives |
US5217994A (en) * | 1991-08-09 | 1993-06-08 | Merck & Co., Inc. | Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives |
DE4129603A1 (de) * | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
AU674553B2 (en) * | 1992-10-14 | 1997-01-02 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
AU675689B2 (en) * | 1992-12-01 | 1997-02-13 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
AU689762B2 (en) * | 1992-12-21 | 1998-04-09 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
US5563158A (en) * | 1993-12-28 | 1996-10-08 | The Dupont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
EP0760658B1 (en) * | 1994-05-27 | 2002-11-13 | Merck & Co. Inc. | Compounds for inhibiting osteoclast-mediated bone resorption |
WO1996000574A1 (en) * | 1994-06-29 | 1996-01-11 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
NZ290008A (en) * | 1994-06-29 | 1998-08-26 | Smithkline Beecham Corp | Vitronectin receptor antagonists, comprising a fibrinogen antagonist analogue linked to a heterocycle |
WO1996026190A1 (en) * | 1995-02-22 | 1996-08-29 | Smithkline Beecham Corporation | Integrin receptor antagonists |
DE19516483A1 (de) * | 1995-05-05 | 1996-11-07 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
PT910563E (pt) * | 1995-06-29 | 2003-09-30 | Smithkline Beecham Corp | Antagonistas de receptores de integrina |
HUP9901116A2 (hu) * | 1995-12-29 | 2000-03-28 | Smithkline Beecham Corporation | Vitronektin receptor antagonisták |
TR199801253T2 (xx) * | 1995-12-29 | 1998-12-21 | Smithkline Beecham Corporation | Vitronektin resept�r� antagonistleri. |
CN1209063A (zh) * | 1995-12-29 | 1999-02-24 | 史密丝克莱恩比彻姆公司 | 玻连蛋白受体拮抗剂 |
DE59706273D1 (de) * | 1996-03-20 | 2002-03-21 | Hoechst Ag | Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
DE19629816A1 (de) * | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
DE19629817A1 (de) * | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
-
1996
- 1996-12-20 DE DE19653645A patent/DE19653645A1/de not_active Withdrawn
-
1997
- 1997-12-12 EP EP97121931A patent/EP0854145A3/de not_active Withdrawn
- 1997-12-17 BR BR9706386-0A patent/BR9706386A/pt not_active IP Right Cessation
- 1997-12-17 ZA ZA9711315A patent/ZA9711315B/xx unknown
- 1997-12-18 NZ NZ329429A patent/NZ329429A/xx unknown
- 1997-12-18 AU AU48464/97A patent/AU729760B2/en not_active Ceased
- 1997-12-18 CZ CZ974112A patent/CZ411297A3/cs unknown
- 1997-12-18 AR ARP970105994A patent/AR010369A1/es unknown
- 1997-12-18 IL IL12264397A patent/IL122643A0/xx unknown
- 1997-12-18 ID IDP973917A patent/ID19245A/id unknown
- 1997-12-18 TR TR97/01645A patent/TR199701645A2/xx unknown
- 1997-12-19 NO NO975975A patent/NO975975L/no not_active Application Discontinuation
- 1997-12-19 CA CA002225267A patent/CA2225267A1/en not_active Abandoned
- 1997-12-19 CN CN97129789A patent/CN1200373A/zh active Pending
- 1997-12-19 HU HU9702509A patent/HUP9702509A3/hu unknown
- 1997-12-20 PL PL97323968A patent/PL323968A1/xx unknown
- 1997-12-20 KR KR1019970071175A patent/KR19980064419A/ko not_active Application Discontinuation
- 1997-12-22 US US08/995,522 patent/US5990145A/en not_active Expired - Lifetime
- 1997-12-22 JP JP9365528A patent/JPH10182617A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
HUP9702509A3 (en) | 2001-04-28 |
BR9706386A (pt) | 2003-04-22 |
TR199701645A3 (tr) | 1998-07-21 |
MX9710389A (es) | 1998-08-30 |
CZ411297A3 (cs) | 1998-07-15 |
US5990145A (en) | 1999-11-23 |
PL323968A1 (en) | 1998-06-22 |
NO975975D0 (no) | 1997-12-19 |
NZ329429A (en) | 1999-05-28 |
JPH10182617A (ja) | 1998-07-07 |
AU729760B2 (en) | 2001-02-08 |
AU4846497A (en) | 1998-06-25 |
ID19245A (id) | 1998-06-28 |
KR19980064419A (ko) | 1998-10-07 |
DE19653645A1 (de) | 1998-06-25 |
ZA9711315B (en) | 1998-06-22 |
HUP9702509A2 (hu) | 1999-06-28 |
IL122643A0 (en) | 1998-08-16 |
NO975975L (no) | 1998-06-22 |
CA2225267A1 (en) | 1998-06-20 |
HU9702509D0 (en) | 1998-03-02 |
EP0854145A2 (de) | 1998-07-22 |
CN1200373A (zh) | 1998-12-02 |
TR199701645A2 (xx) | 1998-07-21 |
EP0854145A3 (de) | 2000-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR010369A1 (es) | Antagonista de receptor vitronectina, su preparacion asi como su empleo. | |
AR006273A1 (es) | Compuestos heterociclicos nitrogenados de anillos de 5 miembros como nuevos inhibidores de la resorcion osea y antagonistas de receptores de vitronectina,procedimiento para su preparacion, utilizacion de dichos compuestos para la preparacion de un medicamento, y preparado farmaceutico. | |
DE60328690D1 (de) | 1-aryl-4-substituierte piperazin-derivate zur verwendung als ccr1-antagonisten zur behandlung von entzündungen und immunerkrankungen | |
ATE349434T1 (de) | Lactamderivaten zur verwendung als humane 11cby rezeptorantagonisten | |
ES2175066T3 (es) | Antagonistas triciclicos de la vasopresina. | |
EE200000778A (et) | 4-bensüülpiperidiinalküülsulfoksiidi heterotsüklid ja nende kasutamine NMDA retseptori alaliikide suhtes selektiivsete antagonistidena | |
PT1379511E (pt) | Derivados de di-hidro-benzo[b] [1,4] diazepin-2-ona como antagonistas ii de r2glum | |
PT1379522E (pt) | Derivados de di-hidro-benzo[b] [1,4] diazepina-2-ona como antagonistas i do r2glum | |
DE69940063D1 (de) | Biphenylsulfonamide als zweifach aktive rezeptor antagonisten von angiotensin und endothelin | |
ECSP045139A (es) | DERIVADOS DE ACETILENO QUE TIENEN ACTIVIDAD ANTAGONISTICA DE MGluR5 | |
DK1288205T3 (da) | Nye phenylalanin-derivater | |
AR025883A1 (es) | Utilizacion de antagonistas de los receptores de los cannabinoides centrales para la preparacion de medicamentos | |
FI960727A0 (fi) | Neurokiniiniantagonisteina käyttökelpoiset heterosyklit | |
AR010700A1 (es) | Derivados de purina sustituidos, procedimiento para su preparacion, su empleo y su agente que los contiene | |
DE60203797D1 (de) | Benzo[d]azepin-derivative als 5-ht6-rezeptor-antagonisten | |
ATE304530T1 (de) | Substituierte 1,5-dihydropyrrol-2-on-derivate wirksam als nmda-rezeptor-antagonisten für die behandlung von schmerzzuständen | |
BR9909486A (pt) | Compostos calcilìticos | |
UY28519A1 (es) | Derivados de quinazolina | |
ATE302763T1 (de) | Bicyclische cyclohexylamine und ihre verwendung als nmda-rezeptor antagonisten | |
ATE369348T1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
PT1200400E (pt) | Derivados de pirrolidino-2,3,4-trion-3-oxina substituidas com eficacia como antagonistas do receptor nmda | |
BR0213574A (pt) | Compostos básicos lineares apresentando atividade antagonista do nk-2 e formulações contendo os mesmos | |
ATE279923T1 (de) | Urotensin-ii rezeptorantagonisten | |
MX9202616A (es) | Nuevos hetariloxi-beta-carbolinos, su produccion y uso en agentes farmaceuticos. | |
UY26329A1 (es) | Antagonistas de los receptores de vitronectina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |